A five-year longitudinal study of the relation between end-stage kidney disease as the outcomes.

ABSTRACT:

Background

Patients with end-stage kidney disease (ESKD) are required to undergo consecutive time-based blood and biochemical tests to determine the progression of the disease according to changes in their blood and biochemical data. This study employed a random intercept model to investigate whether time-based blood and biochemical data present any notable clinical meaning that can be used to track disease progression.

Methods

This study conducted a retrospective analysis on the dialytic data of 148 patients with ESKD, who received hemodialysis between January 2005 and December 2015. The patients were all at least 20 years old, and the data used included patient demographic information and results for at least 60 blood and biochemical tests. A random intercept model was use

SUBMITTER: Li HL 

PROVIDER: S-EPMC7161172 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature